Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-994-5 | CAS number: 16926-87-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April - July 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Version / remarks:
- February 2015
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- activation of keratinocytes
Test material
- Reference substance name:
- 2-hydroxy-3-phenoxypropyl methacrylate
- EC Number:
- 240-994-5
- EC Name:
- 2-hydroxy-3-phenoxypropyl methacrylate
- Cas Number:
- 16926-87-7
- Molecular formula:
- C13H16O4
- IUPAC Name:
- 2-hydroxy-3-phenoxypropyl 2-methylprop-2-enoate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material:
171512
- Expiration date of the lot/batch:
23 December 2019
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material:
At room temperature
In vitro test system
- Details of test system:
- Keratinoses transgenic cell line [442D]
- Details on the study design:
- KeratinoSens cells: the cell line KeratinoSens is stably transfected with a modified plasmid. This plasmid contains an ARE sequence from the AKR1C2 gene and a SV40 promotor which are inserted upstream of a luciferase gene. The resulting plasmid was transfected into HaVaT keratinocytes and clones with a stable insertion selected in the presence of Geneticin / G-418. Induction of luciferase gene is the endpoint evaluated and reflects the activation by the test item of the Nrf2 transcription factor in this test.
Supplier: this cell line was provided by Givaudan
Batch: D1
Storage conditions: at -80ºC
Mycoplasm: absence of mycoplasm was confirmed
Results and discussion
- Positive control results:
- First run: all acceptance criteria were fulfilled for the positive and negative controls.
Second run: all acceptance criteria were fulfilled for the positive and negative controls. The criterion "the average induction (Imax) in the three replicate plates for the positive control at 64µM should be between 2 and 8" was not fulfilled (i.e. Imax = 9.65). However since a clear dose-response with increasing luciferase activity at increasing concentrations was obtained for the positive control, this was considered not to have any impact on the validity of the results of this run
In vitro / in chemico
Resultsopen allclose all
- Key result
- Group:
- test chemical
- Run / experiment:
- run/experiment 2
- Parameter:
- EC 1.5 [442D]
- Value:
- 62.99 µM
- Cell viability:
- viable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Group:
- test chemical
- Run / experiment:
- run/experiment 1
- Parameter:
- EC 1.5 [442D]
- Value:
- 49.38 µM
- Cell viability:
- viable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Outcome of the prediction model:
- positive [in vitro/in chemico]
- Other effects / acceptance of results:
- First run:
- no precipitate/emulsion was observed in an test item-treated wells at the end of the 48 hr period.
- a decrease in cell viability (<70%) was noted at concentrations >=1000µM
- the corresponding IC30 and IC50 were calculated to be 618.35 and 729.90µM, respectively
-statistically gene-fold inductions above the threshold of 1.5 were noted at concentrations >= 62.5 µM and up to 500µM with a dose-response
- The Imax was 21.91 and the calculated EC1.5 was 49.38µM
Second run:
- no precipitate/emulsion was observed in an test item-treated wells at the end of the 48 hr period.
- a decrease in cell viability (<70%) was noted at concentrations >=1000µM
- the corresponding IC30 and IC50 were calculated to be 595.33 and 825.59µM, respectively
-statistically gene-fold inductions above the threshold of 1.5 were noted at concentrations >= 125 µM and up to 500µM with a dose-response
- The Imax was 17.55 and the calculated EC1.5 was 62.99µM4
Any other information on results incl. tables
Results analysis
Data evaluation was performed using a validated Excel sheet. The generated raw data (luminescence data for the luciferase activity and absorbance data for the MTT test) were pasted into an Excel template, and all data procesing was performed automatically.
For the MTT and the luciferase data, the background value recorded in the empty well withour cells (blank) was substracted.
For MTT data, the % viability was calculated for each well in the test plate in relation to average of the six negative contol wells.
For the luciferase data, the average value of the six negative control wells was set to 1, and for each well in the plate, the fold induction was calculated in relation to this value.
For wells in which a statistically significant gene-induction (using a student test, also called T-test) over the 1.5 threshold was found, the following parameters were calculated from the processed raw data:
-Imax: maximal induction factor of luciferase activity compared to the negative control over the complete dose-response range measured,
- EC1.5: Concentration at which a 1.5 -fold luciferase gene induction is obtained,
- IC50 and IC30: concentrations effecting a reduction of cellular viability of 50% and 30%,
Indication whether significant 1.5 -fold gene induction occured below the IC30
The data were plotted in graphs and the Imax and the EC1.5 values were visually checked since uneven dose-response curves or large variation may lead to wrong extrapolations.
Also, the individual and overall geometric means IC50 and IC30 were calculated, when applicable.
Acceptance and Evaluation criteria
Acceptance criteria
Each run was considered valid if the following criteria were met:
- the positive control results should be positive, thus the gene induction should be statistically significant above the threshold of 1.5 in at least one of the tested concentrations.
- the average EC1.5 value for the positive control should be within two standard deviations of the historical mean. In addition, the average induction (Imax) in the three replicate plates for the positive control of 64 µM should be between 2 and 8. If the latter criterion was not fulfilled, the dose-response of Cinnamic Aldehyde was carefully checked, and the run was accepted if there was a clear dose-response with increasing luciferase activity at increasing concentration for the positive control,
- the average coefficient of variation of the luminescence reading in the negative control wells of the triplicate plates should be <20%.
Evaluation criteria of the test item
The results of each run are analyzed individually and if the test item is classified as positive in two runs, the final outcome is considered positive. If the test item is classified as negative in two runs, the final outcome is negative. In case, the first two runs were not concordant, a third run was performed and the final outcome was that of the two concordant runs.
The test item is considered as positive if the following four conditions are all met in two of two or in two of three runs, otherwise the KeratinoSens prediction is considered as negative:
- Imax is > 1.5 -fold and statistically significantly different as compared to the negative control (as determined by a two-tail, unpaired Student's T-test),
- at the lower concentration with a gene induction> 1.5 -fold (i.e. at the EC1.5 determining value), the cell viabillity is >70%,
- the EC1.5 value is < 1000 µM (or < 200µg/mL for test item without MW),
- there is an appropriate overall dose-response for luciferase induction (or a reproducable biphasic response).
Results
Solubility Test
In the solubility test, the test item was found stable in DMSO at 200mM. Therefore this vehicle was selected for the preparation of the test item stock formulations.
No precipitate or emulsion was observed once the test item stock formulation was diluted in the treatment culture medium to a final concentration of 2000 µM.
KeratinoSens run (Appendices 2 and 3)
The Imax, IC30, IC50, EC1.5 and viability values obtained for cells treated with the test item in each run as well as the mean and SD values are presented in Appendix 2. The viablity values (%), induction values, Imax, IC30, IC50 and EC1.5 values obtained with the positive control are presented in Appendix 3. In addition the luminescence values of all negative control wells ant the %CV between these values for each run are also presented in Appendix 3.
First run
All acceptance criteria were fulfilled for the positive and negative controls. The run was therefore considered to be valid.
This run was performed using the following concentrations 0.98, 1.95, 3.91, 7.81, 15.63, 31.25, 62.5, 125, 250, 500, 1000 and 2000 µM in culture medium containing 1% DMSO.
At these tested concentrations:
- no precipitate/emulsion was observed in any test item treated wells at the end of the 48-hour treatment period,
- a decrease in cell viability (i.e. cell viability <70%) was noted at concentration >= 1000µM,
- the coresponding IC30 and IC50 were calculated to be 618.35 and 729.90 µM respectively,
- statistically gene-fold inductions above the threshold of 1.5 were noted at concentrations >= 62.5µM and up tp 500 µM with a dose-response,
- the Imax was 21.91 and the calculated EC1.5 was 49.38 µM.
Second run
All acceptance criteria were met for the positive and negative controls, this run was therefore considered to be valid. The citerion "the average induction (Imax) in the three replicate plates for the positive control at 64 µM should be between 2 and 8" was not fulfilled (i.e. Imax of 9.65). Howwever, since a clear dose-response with increasing luciferase activity at increasing concnetrations was obtained for the positive control, this was considered not the have any impact on the validity of the results of this run.
The same concentrations as thos in run 1 were used.
At these tested concentrations:
- no precipitate/emulsion was observed in ny test item-treated wells a the end of the 48 -hour treatment period,
- a decrease in cell viability (i.e. cell viability <70%) was noted at concentration >= 1000µM,
- the corresponding IC30 and IC50 were calculated to be 595.33 and 825.59 µM, respectively,
- statistically gene-fold inductions above the threshold of 1.5 were noted at concentrations of >125 µM and up to 500 µM with a dose-response,
- the Imax was 17.55 and the calculated EC1.5 was 62.99 µM.
The evaluation criteria for a positive response are met in both runs, the final outcome is therefore positive. This positive result can be used to support the discrimination between skin sensitizers and non-sensitizers in the context of an integrated approach to testing and assessment.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Under the experimental conditions of this stuy, the test item, 3-phenoxy-2-hydroxypropyl methacrylate, was positive in the KeratinoSens assay and therefore was considered to activate the Nrf2 transcription factor.
- Executive summary:
Summary
The objective of this study was to evaluate the potential of the test item, 3 -phenoxy-2 -hydroxypropyl methacrylate, to activate the Nrf2 transcription factor. This test is part of the tiered strategy for the evaluation of skin sensitiation potential. Thus, data generated with the present Test Guideline should be used to support the descrimination between skin sensitizers and non-sensitizers in the context of an integrated approach to testing and assessment.
Principle
This in vitro test uses the KeratinoSens cell line, an immortalized and genetically modified Human adherant HaCaT keratinocyte cell line. The KeratinoSens cell line is stabaly transfected with a plasmid containing a luciferase gene under the transcriptional control of the SV40 origin of replication promoter. This promoter is fused with an ARE sequence. Sensitizers with electrophilic properties provoke the dissociation of Keap-1 from the transcription factor Nrf2. The free Nrf2 binds to the ARE sequence contained in the plasmid and therefore induces transcription of firefly luciferase.
Methods
The KeratinoSens cells were first plated on 96 -well plates and grown for 24 hours at 37°C. Then the medium was removed and the cells were exposed to the vehicle control or to difference concentraions of test item and of positive controls. The treated plates were then incubated for 48 hours at 37ºC. At the end of the treatment, cells were washed and the luciferase production was measured by flash luminescense. In parallel, the cytotoxicty was measured by MTT reduction test and was taken into consideration in the interpreatation of the sensitisation results. Two independant runs were performed.
Results
For each run, the test item was solubilised in DMSO at 200mM.
First run
All acceptance criteria were fulfilled for the positive and negative controls. The run was therefore considered to be valid.
This run was performed using the following concentrations 0.98, 1.95, 3.91, 7.81, 15.63, 31.25, 62.5, 125, 250, 500, 1000 and 2000 µM in culture medium containing 1% DMSO.
At these tested concentrations:
- no precipitate/emulsion was observed in any test item-treated wells at the end of the 48 -hour treatment period,
- a decrease in cell viability (i.e. cell viability <70%) was noted at concnetrations >= 1000µM,
- the corresponding IC30 and IC50 were calculated to be 61.35 and 729.90 respectively,
- statistically gene-fold inductions above the threshold of 1.5 were noted at concentrations >= 62.5 µM and up to 500µM with a dose-response,
- the Imax was 21.91 and the calculated EC1.5 was 49.38 µM
Second run
All acceptance critera were met for the positive and negative controls, this run was therefore considered to be valid. The criterion "the average induction (Imax) in the three replicate plates for the positive control at 64 µM should be between 2 and 8" was not fulfilled (i.e. Imax 9.65). However, since a clear dose-response with increasing luciferase activity at increasing concentrations was obtained for the positive control, this was considered not to have any impact on the validity of the results of this run.
The same concentrations as those in the run 1 were used.
At these tested concentrations:
- no precipitate/emulsion was observed in any test item-treated wells at the end of the 48 -hour treatment period,
- a decrease in cell viabilty (i.e. cell viability <70%) was noted at concentration >= 1000µM,
- the corresponding IC30 and IC50 were calculated to be 595.33 and 825.59 µM respectively,
- statistically gene-fold inductions above the threshold of 1.5 were noted at concentrations >=125 µM and up to 500µM with a dose-response,
- the Imax was 17.55 and the calculated EC1.5 was 62.66 µM
Conclusion
Under the experimental conditions of this study, the test item, 3 -phenoxy-2 -hydroxypropyl methacrylate, was positive in the KeratinoSens assay and therefore was considered to activate the Nrf2 transcription factor.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.